|
|
Effects of Biguanides on Intestinal Flora and Glucose and Lipid Metabolism in Elderly Patients with T2DM |
XU Xian-feng |
Changsha hospital of traditional Chinese medicine, Hunan Changsha 410100 |
|
|
Abstract 【Objective】 To investigate the clinical effect of biguanides on intestinal flora imbalance and metabolic disorder in elderly patients with T2DM. 【Methods】 A total of 150 elderly patients with T2DM who were treated in our hospital from January 2018 to June 2019 were selected and randomly divided into observation group and control group. The observation group was given metformin, and the control group was given placebo. The changes of intestinal flora, inflammatory indexes and metabolism of the two groups were compared before and after treatment. 【Results】 Between the two groups, there was no significant difference in the number of intestinal flora before treatment (P>0.05); After treatment, The number of Bifidobacterium and Lactobacillus increased significantly in the observation group, However, the number of Enterobacter and Enterococcus were significantly decreased (P<0.05); There was no significant difference in fasting blood glucose (FPG), postprandial 2h glucose (2hPG), triacylglycerol (TG), C-reactive protein (CRP), tumor necrosis factor between the two groups (P>0.05); After treatment, All the FPG、2hPG、TG、CRP、TNF-α levels in the observation group were significantly lower than those in the control group, All the differences were statistically significant (P<0.05). 【Conclusion】 Biguanides can better correct the imbalance of intestinal flora in elderly patients with T2DM, increase the number of beneficial bacteria, reduce the number of harmful bacteria, and correct metabolic disorders, which is worthy of clinical application.
|
Received: 13 March 2020
|
|
|
|
|
[1] 李天艺, 李华, 焦文君, 等. 二甲双胍对老年2型糖尿病炎症和肠道菌群失衡的临床疗效研究[J].中华老年医学杂志, 2018, 37(8):879-882.
[2] 张思敏, 韩学尧, 纪立农. 二甲双胍治疗2型糖尿病的药物基因组学研究进展[J].中国糖尿病杂志, 2017, 25(8):760-764.
[3] 肖叔敏, 于珮. 肠道菌群与2型糖尿病及并发症[J].世界华人消化杂志 2017, 25(20): 1819-1831.
[4] 余丹, 叶山东, 李业琼,等. 二甲双胍对2型糖尿病模型大鼠肾功能及肾组织SIRT1表达的影响[J].中国药理学通报, 2018, 34(5):30-34.
[5] 秦凤, 李春亮, 张惠莉. 二甲双胍对2型糖尿病模型大鼠胰岛素抵抗的影响[J].中国组织工程研究, 2017, 21(12):1909-1914.
[6] 李潇潇, 于美玲, 卢圣锋,等. 肠道菌群与肠上皮细胞在高脂高糖诱导的2型糖尿病中的作用及意义[J].中国糖尿病杂志, 2017, 25(9):842-846.
[7] 马苏娴, 张锐锐, 王苏,等. 2型糖尿病患者肠道菌群变化及意义[J].山东医药, 2017, 57(16):20-23.
[8] 田佳星, 李敏, 仝小林. 肠道微生态与2型糖尿病关系的研究进展[J].中国糖尿病杂志, 2018, 26(8):78-81.
[9] 徐珂莹, 归崎峰, 杨云梅. 老年2型糖尿病患者肠道厚壁菌群研究[J].中华老年医学杂志, 2017, 36(2):195-198. |
|
|
|